The role of androgens in rheumatic diseases

Israel Medical Association Journal

Volumn 3, Issue 10, 2001, Pages 743-748

  Cutolo, Maurizio ^a   Seriolo, Bruno ^a   Pizzorni, Carmen ^a   Sulli, Alberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Adjuvant therapy; Androgens; Lymphocytes; Macrophages; Rheumatic diseases; Rheumatoid arthritis

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN; ANDROSTANEDIOL; AROMATASE; CORTICOTROPIN; CORTISONE; CYCLOSPORIN A; CYTOCHROME P450C17; DANAZOL; ESTRADIOL; ESTRONE; GLUCOCORTICOID; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 6; METHOTREXATE; NANDROLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PRASTERONE; PRASTERONE SULFATE; STEROID 17,20 LYASE; STEROID 17ALPHA MONOOXYGENASE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE PROPIONATE; TESTOSTERONE UNDECANOATE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ADJUVANT THERAPY; ANDROGEN BLOOD LEVEL; ANDROGEN METABOLISM; ANDROGEN RELEASE; ANDROGEN SYNTHESIS; BIOSYNTHESIS; CLINICAL TRIAL; DISEASE COURSE; DOSE RESPONSE; DRUG BLOOD LEVEL; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HYPERTRICHOSIS; MACROPHAGE; MENSTRUATION DISORDER; MONOCYTE; POSTMENOPAUSE; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; STEROID THERAPY; T LYMPHOCYTE; VIRILIZATION;

ANDROGENS; AROMATASE; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNITY, CELLULAR; MALE; T-LYMPHOCYTES;

EID: 0035694064     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases
2. Sex hormone adjuvent therapy in rheumatoid arthritis
3. Integrated hormonal-immunological-vascular (H-I-V) systems interactions in the rheumatic diseases
4. Immunomodulatory mechanisms mediated by sex hormones in rheumatoid arthritis
5. The roles of steroid hormones in arthritis
6. Several environmental estrogens are also anti-androgens
7. Persistent DDT metabolite p,p'-DDe is a potent androgen receptor antagonist
8. Linkage of a marker in intron D of the estrogen synthase locus to rheumatoid arthritis
9. Perturbations of the hypothalamic pituitary gonadal axis in rheumatoid arthritis
10. Possible association of CYP17 gene polymorphism with the onset of rheumatoid arthritis
11. The role of the hypothalamus-pituitary-adrenocortical and gonadal axis in rheumatoid arthritis
12. CYP17 gene polymorphisms and androgen levels in postmenopausal patients with rheumatoid arthritis
13. Sex hormone status in women suffering from rheumatoid arthritis
14. Polymorphic CAG repeats of the androgen receptor gene and rheumatoid arthritis
15. Sex hormones, HLA and rheumatoid arthritis
16. Major histocompatibility complex phenotypes influence serum testosterone concentration
17. Effects of sex steroids on immunoglobulin M production by Epstein-Barr virus-transformed B-cell line SKW6-CL4
18. Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells
19. Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
20. 17β-estradiol, but not dihydrotestosterone augments antibodies to double-stranded deoxyribonucleic acid in nonautoimmune C57BL/6J mice
21. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and IFN-gamma, but not IL-2 by activated murine T cells
22. Testosterone ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in autoantigen-specific T lymphocyte response
23. Primary cultures of human synovial macrophages metabolize androgens
24. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro
25. Androgen metabolism and inhibition of interleukin-1 synthesis in primary cultured human synovial macrophages
26. A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women
27. Androgen replacement therapy in male patients with rheumatoid arthritis
28. Androgens as adjuvant treatment in postmenopausal patients with rheumatoid arthritis
29. A randomized trial of testosterone therapy in males with rheumatoid arthritis
30. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months
31. Viewpoint: Should dehydroepiandrosterone (DHEA) replacement therapy be provided with glucocorticoids?
32. Effects of gonadal androgens on adrenal androgens
33. Increase in serum 5α-androstane-3α, 17β-diol glucuronide (3α-diol G) as a possible marker of the androgen-mediated immunosuppressive activity exerted by cyclosporin A: Preliminary results
34. Testosterone metabolism and cyclosporin A treatment in rheumatoid arthritis
35. Androgenizing effects of low-dose cyclosporin in male patients with early RA
36. Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from rheumatoid arthritis patients
37. Adrenocorticotropin, glucocorticoid, androgen secretion in patients with new onset synovitis/rheumatoid arthritis: Relations with indices of inflammation
38. Do androgens influence the pathophysiology of rheumatoid arthritis? Facts and hypotheses
39. Polymyalgia rheumatica: Evidence for a hypothalamic-pituitary-adrenal axis-driven disease
40. Impact of the hypothalamic-pituitary-adrenal/gonadal axes and the peripheral nervous system in rheumatoid arthritis: A systemic pathogenic view point